상세 보기
Phase I/II study of mezigdomide and elranatamab for relapsed/refractory multiple myeloma patients (MELT-MM): Initial results from part 1
- Byun, Ja Min;
- Min, Chang-Ki;
- Kim, Kihyun;
- Yoon, Dok Hyun;
- Jung, Sung-Hoon;
- 외 3명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Phase I/II study of mezigdomide and elranatamab for relapsed/refractory multiple myeloma patients (MELT-MM): Initial results from part 1
- 저자
- Byun, Ja Min; Min, Chang-Ki; Kim, Kihyun; Yoon, Dok Hyun; Jung, Sung-Hoon; Chng, Wee-Joo; Nagarajan, Chandramouli; Koh, Youngil
- 발행일
- 2025-11-03
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146